Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-Amoxicillin Dual Therapy for H. Pylori Eradication
NCT05469685Phase 4Completed
- Sponsor
- Nanjing First Hospital
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by Nanjing First Hospital. Started Aug 2022; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05469685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05469685.